SLLS
評論了
獲利者:
• $安塔爾製藥 (ATRS.US)$ 增加 48.7%(將由哈洛西姆(HALO)以每股 5.60 美元收購)
• $Sierra Oncology (SRRA.US)$ 增加 37.9%(GSK 以每股 55 美元收購)
• $Amryt Pharma (AMYT.US)$ 增加 11.7%(公布第二年 OPTIMAL 開放標籤延伸研究對乳症患者的 Mycapssa(口服奧特雷奧特)的長期安全和有效性數據正面)
• $BriaCell Therapeutics (BCTX.US)$ +6%(顯示... 的發展細節)
• $安塔爾製藥 (ATRS.US)$ 增加 48.7%(將由哈洛西姆(HALO)以每股 5.60 美元收購)
• $Sierra Oncology (SRRA.US)$ 增加 37.9%(GSK 以每股 55 美元收購)
• $Amryt Pharma (AMYT.US)$ 增加 11.7%(公布第二年 OPTIMAL 開放標籤延伸研究對乳症患者的 Mycapssa(口服奧特雷奧特)的長期安全和有效性數據正面)
• $BriaCell Therapeutics (BCTX.US)$ +6%(顯示... 的發展細節)
已翻譯
12
4
SLLS
讚了
My youtube channel:
https://www.youtube.com/channel/UCAPWOEQKCpCWmzKkdo7v-iw
Xiaomi is showing resilience today finally after breaking 20 then 19 then 18 HKD before making a small gain today from 18.12 to 18.22 HKD. This is considered a blessing since Hang Seng Tech tanked close to 2.5%. Companies like Kuaishou Tech, Alibaba, Bilibili, Netease, Meituan, etc all came down by close to 3%... Well is it that Xiaomi has already fallen to the value territory and the point that it doesnt make sense for it to go further?
I cant say that for sure but the chip shortage, poor IR handling skills, handset competition in China and other markets plus the capital worries for the EV unit may weigh on Xiaomi... But so what? There was even the concern that Lei Jun had to step down from key business units may signal some problems.
Then again when Lei Jun emerged as the controlling individual of the Venture Cap or rather PE arm of Xiaomi, such panic over Lei Jun abated which may explain for today's resilience. Of course another part could be Xiaomi own share buyback. Even with the share buyback all the way from 27 HKD down to 18 HKD, such share buyback pales and cant work when the narrative and downside pressure over whatever can be said weigh on Xiaomi..
But VALUE WILL EVENTUALLY EMERGE.. will the IPO Price of 17 HKD provide a strong support? Only time will tell but I am a truly long-term investor of Xiaomi...
See this youtube video by me on Xiaomi if you want to know why I believe in Xiaomi:
https://www.youtube.com/watch?v=glRHKF1fQkU
As always, this should not be construed as any investment or trading advice.
$小米集團-W (01810.HK)$ $小米集團(ADR) (XIACY.US)$ $LENOVO B2401 (05562.HK)$ $海爾智家 (600690.SH)$ $海爾智家 (06690.HK)$
https://www.youtube.com/channel/UCAPWOEQKCpCWmzKkdo7v-iw
Xiaomi is showing resilience today finally after breaking 20 then 19 then 18 HKD before making a small gain today from 18.12 to 18.22 HKD. This is considered a blessing since Hang Seng Tech tanked close to 2.5%. Companies like Kuaishou Tech, Alibaba, Bilibili, Netease, Meituan, etc all came down by close to 3%... Well is it that Xiaomi has already fallen to the value territory and the point that it doesnt make sense for it to go further?
I cant say that for sure but the chip shortage, poor IR handling skills, handset competition in China and other markets plus the capital worries for the EV unit may weigh on Xiaomi... But so what? There was even the concern that Lei Jun had to step down from key business units may signal some problems.
Then again when Lei Jun emerged as the controlling individual of the Venture Cap or rather PE arm of Xiaomi, such panic over Lei Jun abated which may explain for today's resilience. Of course another part could be Xiaomi own share buyback. Even with the share buyback all the way from 27 HKD down to 18 HKD, such share buyback pales and cant work when the narrative and downside pressure over whatever can be said weigh on Xiaomi..
But VALUE WILL EVENTUALLY EMERGE.. will the IPO Price of 17 HKD provide a strong support? Only time will tell but I am a truly long-term investor of Xiaomi...
See this youtube video by me on Xiaomi if you want to know why I believe in Xiaomi:
https://www.youtube.com/watch?v=glRHKF1fQkU
As always, this should not be construed as any investment or trading advice.
$小米集團-W (01810.HK)$ $小米集團(ADR) (XIACY.US)$ $LENOVO B2401 (05562.HK)$ $海爾智家 (600690.SH)$ $海爾智家 (06690.HK)$
59
SLLS
讚了
更新版本第 1 部分 $BLU — 股票和期權播放
需要突破:7.07 美元
更多上升趨勢的關鍵指標 7.16 美元
確認上升趨勢 -7.23 美元
迷你突破-7.45 美元
全面突破-7.58 美元
半拋物線-7.68 美元
止損 — 6.62 美元
和支持-6.15 美元。 $BELLUS Health (BLU.US)$
需要突破:7.07 美元
更多上升趨勢的關鍵指標 7.16 美元
確認上升趨勢 -7.23 美元
迷你突破-7.45 美元
全面突破-7.58 美元
半拋物線-7.68 美元
止損 — 6.62 美元
和支持-6.15 美元。 $BELLUS Health (BLU.US)$
已翻譯
4
SLLS
讚並評論了
全新 $ROUNDHILL MEME ETF (MEME.US)$ 是現場直播的,有了投資各種模因股票的機會。
根據 Roundhill MEME ETF 網站的資料,它追蹤了「25 隻同等加權的美國上市股票證券,這些證券結合了社交媒體活動升高和高短期利率。」還值得指出的是,該 ETF 中的許多公司都是便士股。因此,請小心處理。
圓山米姆 ETF 十強控股
1. $ContextLogic (WISH.US)$ 股票讓我們成為 4.39% 的最大持有量。
2. $Digital World Acquisition Corp (DWAC.US)$ 股份上漲下一個 4.36% 持有。
3. $Upstart (UPST.US)$ 股票以 4.34% 的重量加入列表。
4. $DraftKings (DKNG.US)$ 股份以 4.24% 持有的名單。
5. $SoFi Technologies (SOFI.US)$ 股票以 4.21% 的重量擊中了中途點。
6. $Snap Inc (SNAP.US)$ 是交易所買賣基金的另一隻模因股票,持有 4.14%。
7. $AMC院線 (AMC.US)$ 是一個主要的模因股,ETF 持有 4.11% 的股份。
8. $Clover Health (CLOV.US)$ 股票以 4.11% 的重量將其位置固定在列表中。
9. $Teladoc Health (TDOC.US)$ 股份接近尾,持有 4.09%。
10. $Tilray Brands (TLRY.US)$ 股票完成了前 10 名圓山 MEME ETF 持有的 4.06%。
根據 Roundhill MEME ETF 網站的資料,它追蹤了「25 隻同等加權的美國上市股票證券,這些證券結合了社交媒體活動升高和高短期利率。」還值得指出的是,該 ETF 中的許多公司都是便士股。因此,請小心處理。
圓山米姆 ETF 十強控股
1. $ContextLogic (WISH.US)$ 股票讓我們成為 4.39% 的最大持有量。
2. $Digital World Acquisition Corp (DWAC.US)$ 股份上漲下一個 4.36% 持有。
3. $Upstart (UPST.US)$ 股票以 4.34% 的重量加入列表。
4. $DraftKings (DKNG.US)$ 股份以 4.24% 持有的名單。
5. $SoFi Technologies (SOFI.US)$ 股票以 4.21% 的重量擊中了中途點。
6. $Snap Inc (SNAP.US)$ 是交易所買賣基金的另一隻模因股票,持有 4.14%。
7. $AMC院線 (AMC.US)$ 是一個主要的模因股,ETF 持有 4.11% 的股份。
8. $Clover Health (CLOV.US)$ 股票以 4.11% 的重量將其位置固定在列表中。
9. $Teladoc Health (TDOC.US)$ 股份接近尾,持有 4.09%。
10. $Tilray Brands (TLRY.US)$ 股票完成了前 10 名圓山 MEME ETF 持有的 4.06%。
已翻譯
58
4
SLLS : 尼斯